Bleeding News and Research

RSS

People more likely to use bowel screen test kit with GP letter

A letter of endorsement from their local doctor as well as a 'how-to-do-it' leaflet makes more people take part in bowel screening home tests - says a new study published in the British Journal of Cancer, today.

10 Aug 2011

InVivo announces Platinum sponsorship to W2W spinal cord injury symposium

InVivo Therapeutics today announced the Company's Platinum level sponsorship of the 6th annual Working 2 Walk Science and Advocacy Symposium, which will take place October 16-18, 2011 in Rockville, Maryland.

9 Aug 2011

Foreign aid should enhance, not replace, domestic health spending in developing countries

A case in Uganda of a woman bleeding to death while giving birth "underscores an unintended consequence of global health aid," a Globe and Mail editorial writes, adding that "in some parts of sub-Saharan Africa, a reverse trend is under way; for every $1 of development assistance for health, governments have reduced their spending," according to a study from the Institute for Health Metrics and Evaluation at the University of Washington.

9 Aug 2011

Debate on rationality of coronary angiography in low risk patients continues

A new study reveals that American hospitals vary widely in how they decide who's eligible for an invasive type of heart scan.

9 Aug 2011

HPV-related throat cancer cases increase sharply over the past 10 years

Forty-two-year-old Manahawkin, New Jersey resident David Caldarella can recite a long list of dates off the top of his head. The first one starts with the day he found a lump on the right side of his neck while shaving. It was March 23, 2010. Caldarella immediately called his physician.

8 Aug 2011

Hemophilia Foundation of Michigan announces third annual fundraising walk at the Detroit Zoo

The Hemophilia Foundation of Michigan is pleased to announce: Walkin' on the Wild Side for Hemophilia, its third annual fundraising walk at the Detroit Zoo. Walkin' on the Wild Side for Hemophilia takes place on Sunday, August 28, 2011.

4 Aug 2011

Hopkins stem cell research to examine how gene variants cause blood clotting disorders

4 Aug 2011

Posttraumatic stress disorder linked to persistent fears of recurrent SAH

One-third of patients who have survived a life-threatening subarachnoid hemorrhage (SAH) have disabling symptoms of posttraumatic stress disorder (PTSD), reports a study in the August issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

3 Aug 2011

Scientists look to create blood platelets from stem cells to study genetics of blood clotting disorders

Johns Hopkins scientists have launched a pioneering research program to create, for the first time, human platelet cells from stem cells in order to study inherited blood clotting abnormalities ranging from clots that cause heart attacks and stroke to bleeding disorders. The study is funded by a $9 million grant from the National Institutes of Health (NIH) as part of a nationwide initiative to examine how genetic variations cause heart, lung and blood diseases.

2 Aug 2011

WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events

Iverson Genetic Diagnostics, Inc. announced that the WARFARIN Study was initiated at Colorado Heart & Vascular, P.C. in Denver and other major hospital systems nationwide to assess the utility of genetic testing to determine a personalized warfarin dose for individual patients to reduce their risk of serious bleeding or clotting events.

30 Jul 2011

Inspiration presents OBI-1 pivotal study data on hemophilia at 23rd ISTH congress

Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. presented data from its clinical development program for OBI-1, an intravenous (IV) recombinant porcine factor VIII product (rpFVIII), intended for the treatment of bleeding in people with hemophilia A with inhibitors and in people with acquired hemophilia.

28 Jul 2011

Cardiac rehab can prolong patients' lives and reduce risk of second heart attack

Twenty-eight year-old Alex Holton is an active young Torontonian, but five years ago, shortly after receiving life-saving heart surgery, Alex Holton was unsure he'd ever be active again.

28 Jul 2011

Gates Foundation awards phase 1 grant to St. Joseph's scientist for post-partum research

The Bill and Melinda Gates Foundation has awarded Robert Garfield, PhD, a researcher at St. Joseph's Hospital and Medical Center in Phoenix, a $100,000 phase 1 grant to develop a device to prevent post-partum hemorrhage.

27 Jul 2011

Swedish Orphan Biovitrum, Biogen Idec announce data of rFVIIIFc Phase 1/2a trial for hemophilia A

Biogen Idec and Swedish Orphan Biovitrum today announced Phase 1/2a trial data showing that the companies' long-lasting fully-recombinant factor VIII Fc fusion protein (rFVIIIFc) was well tolerated and demonstrated an approximately 1.7-fold increase in half-life compared with Advate, a commercially-available factor VIII product, in 16 previously-treated patients with severe hemophilia A.

26 Jul 2011

Anesthetic agent isoflurane may treat intracerebral hemorrhage

The anesthetic agent isoflurane may be a useful treatment for intracerebral hemorrhage (ICH)—a type of stroke caused by bleeding inside the brain, reports a study in the August issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

26 Jul 2011

Researchers identify elusive gene responsible for Grey Platelet Syndrome

Researchers have identified an elusive gene responsible for Grey Platelet Syndrome, an extremely rare blood disorder in which only about 50 known cases have been reported. As a result, it is hoped that future cases will be easier to diagnose with a DNA test.

26 Jul 2011

C-sections on the rise: One in three mothers opting for procedure

According to the latest study reports, one in three births in the U.S. are now delivered by Caesarean section, which is an all time high and an increasd of 25 percent over seven years.

24 Jul 2011

FDA approves U.S. launch of Wiskott-Aldrich gene therapy clinical trial

The U.S. Food & Drug Administration (FDA) approved the launching in the U.S. of a clinical trial for gene therapy for a rare immunodeficiency, Wiskott-Aldrich syndrome.

22 Jul 2011

Key finding sheds new light on common bleeding disorders

A simple cut to the skin unleashes a complex cascade of chemistry to stem the flow of blood. Now, scientists at Washington University School of Medicine in St. Louis have used evolutionary clues to reveal how a key clotting protein assembles. The finding sheds new light on common bleeding disorders.

21 Jul 2011

Gene-based test for distinguishing harmless from precancerous pancreatic cysts

Johns Hopkins scientists have developed a gene-based test to distinguish harmless from precancerous pancreatic cysts. The test may eventually help some patients avoid needless surgery to remove the harmless variety.

21 Jul 2011

Bleeding News and Research

People more likely to use bowel screen test kit with GP letter

InVivo announces Platinum sponsorship to W2W spinal cord injury symposium

Foreign aid should enhance, not replace, domestic health spending in developing countries

Debate on rationality of coronary angiography in low risk patients continues

HPV-related throat cancer cases increase sharply over the past 10 years

Hemophilia Foundation of Michigan announces third annual fundraising walk at the Detroit Zoo

Hopkins stem cell research to examine how gene variants cause blood clotting disorders

Posttraumatic stress disorder linked to persistent fears of recurrent SAH

Scientists look to create blood platelets from stem cells to study genetics of blood clotting disorders

WARFARIN Study initiated to assess utility of genetic testing to reduce warfarin-related adverse events

Inspiration presents OBI-1 pivotal study data on hemophilia at 23rd ISTH congress

Cardiac rehab can prolong patients' lives and reduce risk of second heart attack

Gates Foundation awards phase 1 grant to St. Joseph's scientist for post-partum research

Swedish Orphan Biovitrum, Biogen Idec announce data of rFVIIIFc Phase 1/2a trial for hemophilia A

Anesthetic agent isoflurane may treat intracerebral hemorrhage

Researchers identify elusive gene responsible for Grey Platelet Syndrome

C-sections on the rise: One in three mothers opting for procedure

FDA approves U.S. launch of Wiskott-Aldrich gene therapy clinical trial

Key finding sheds new light on common bleeding disorders

Gene-based test for distinguishing harmless from precancerous pancreatic cysts

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News